The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostaglandin E2 Market Research Report 2024
Synopsis
Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
The global Prostaglandin E2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin E2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin E2.
Report Scope
The Prostaglandin E2 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin E2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin E2 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segment by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostaglandin E2 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
The global Prostaglandin E2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin E2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin E2.
Report Scope
The Prostaglandin E2 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin E2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin E2 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segment by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostaglandin E2 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostaglandin E2 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Low Purity(Below 97%)
1.2.3 Purity(Above 97% and Below 99%)
1.2.4 High Purity(Above 99%)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prostaglandin E2 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Treatment
1.3.3 Neurological Treatment
1.3.4 Endocrinological Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostaglandin E2 Market Perspective (2019-2030)
2.2 Prostaglandin E2 Growth Trends by Region
2.2.1 Global Prostaglandin E2 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostaglandin E2 Historic Market Size by Region (2019-2024)
2.2.3 Prostaglandin E2 Forecasted Market Size by Region (2025-2030)
2.3 Prostaglandin E2 Market Dynamics
2.3.1 Prostaglandin E2 Industry Trends
2.3.2 Prostaglandin E2 Market Drivers
2.3.3 Prostaglandin E2 Market Challenges
2.3.4 Prostaglandin E2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostaglandin E2 Players by Revenue
3.1.1 Global Top Prostaglandin E2 Players by Revenue (2019-2024)
3.1.2 Global Prostaglandin E2 Revenue Market Share by Players (2019-2024)
3.2 Global Prostaglandin E2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostaglandin E2 Revenue
3.4 Global Prostaglandin E2 Market Concentration Ratio
3.4.1 Global Prostaglandin E2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostaglandin E2 Revenue in 2023
3.5 Prostaglandin E2 Key Players Head office and Area Served
3.6 Key Players Prostaglandin E2 Product Solution and Service
3.7 Date of Enter into Prostaglandin E2 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostaglandin E2 Breakdown Data by Type
4.1 Global Prostaglandin E2 Historic Market Size by Type (2019-2024)
4.2 Global Prostaglandin E2 Forecasted Market Size by Type (2025-2030)
5 Prostaglandin E2 Breakdown Data by Application
5.1 Global Prostaglandin E2 Historic Market Size by Application (2019-2024)
5.2 Global Prostaglandin E2 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostaglandin E2 Market Size (2019-2030)
6.2 North America Prostaglandin E2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostaglandin E2 Market Size by Country (2019-2024)
6.4 North America Prostaglandin E2 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostaglandin E2 Market Size (2019-2030)
7.2 Europe Prostaglandin E2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostaglandin E2 Market Size by Country (2019-2024)
7.4 Europe Prostaglandin E2 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostaglandin E2 Market Size (2019-2030)
8.2 Asia-Pacific Prostaglandin E2 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostaglandin E2 Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostaglandin E2 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostaglandin E2 Market Size (2019-2030)
9.2 Latin America Prostaglandin E2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostaglandin E2 Market Size by Country (2019-2024)
9.4 Latin America Prostaglandin E2 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostaglandin E2 Market Size (2019-2030)
10.2 Middle East & Africa Prostaglandin E2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostaglandin E2 Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostaglandin E2 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Detail
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems Prostaglandin E2 Introduction
11.1.4 R&D Systems Revenue in Prostaglandin E2 Business (2019-2024)
11.1.5 R&D Systems Recent Development
11.2 Abcam
11.2.1 Abcam Company Detail
11.2.2 Abcam Business Overview
11.2.3 Abcam Prostaglandin E2 Introduction
11.2.4 Abcam Revenue in Prostaglandin E2 Business (2019-2024)
11.2.5 Abcam Recent Development
11.3 Stemgent
11.3.1 Stemgent Company Detail
11.3.2 Stemgent Business Overview
11.3.3 Stemgent Prostaglandin E2 Introduction
11.3.4 Stemgent Revenue in Prostaglandin E2 Business (2019-2024)
11.3.5 Stemgent Recent Development
11.4 Cayman Chemical
11.4.1 Cayman Chemical Company Detail
11.4.2 Cayman Chemical Business Overview
11.4.3 Cayman Chemical Prostaglandin E2 Introduction
11.4.4 Cayman Chemical Revenue in Prostaglandin E2 Business (2019-2024)
11.4.5 Cayman Chemical Recent Development
11.5 Santa Cruz Biotechnology
11.5.1 Santa Cruz Biotechnology Company Detail
11.5.2 Santa Cruz Biotechnology Business Overview
11.5.3 Santa Cruz Biotechnology Prostaglandin E2 Introduction
11.5.4 Santa Cruz Biotechnology Revenue in Prostaglandin E2 Business (2019-2024)
11.5.5 Santa Cruz Biotechnology Recent Development
11.6 STEMCELL Technologies
11.6.1 STEMCELL Technologies Company Detail
11.6.2 STEMCELL Technologies Business Overview
11.6.3 STEMCELL Technologies Prostaglandin E2 Introduction
11.6.4 STEMCELL Technologies Revenue in Prostaglandin E2 Business (2019-2024)
11.6.5 STEMCELL Technologies Recent Development
11.7 AbMole Bioscience
11.7.1 AbMole Bioscience Company Detail
11.7.2 AbMole Bioscience Business Overview
11.7.3 AbMole Bioscience Prostaglandin E2 Introduction
11.7.4 AbMole Bioscience Revenue in Prostaglandin E2 Business (2019-2024)
11.7.5 AbMole Bioscience Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Detail
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne Prostaglandin E2 Introduction
11.8.4 Bio-Techne Revenue in Prostaglandin E2 Business (2019-2024)
11.8.5 Bio-Techne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
